NCT03179592View on ClinicalTrials.gov

VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Coronary Artery DiseaseCardiovascular Diseases
Interventions
DRUG

Ultravist 370Mg I/Ml Solution for Injection

Reduced contrast-volume injection protocols based on patient specific tube voltage.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT03179592 - VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography | Biotech Hunter | Biotech Hunter